Merck & Company, Inc. News Headlines

MRK 
$56.19
*  
0.14
 negative 
0.25%
Get MRK Alerts
*Delayed - data as of Apr. 16, 2014 15:47 ET 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    MRK After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Credit Suisse Upgrades Pharmaceutical Sector: 3 Stocks To Buy, 1 To Avoid
10/3/2012 2:40:00 AM - Seeking Alpha

Merck to Return Vernakalant Rights - Analyst Blog
10/2/2012 4:48:01 PM - Zacks.com

Pfizer Has A Pipeline Of Products
10/2/2012 3:48:00 PM - Seeking Alpha

Dividend Plays In Big Pharma
10/2/2012 1:38:00 PM - Seeking Alpha

Which Big Pharma Is Right For Your IRA?
10/2/2012 12:03:00 PM - Seeking Alpha

What Is The Best Ex-Dividend Opportunity This Week?
10/1/2012 3:48:00 PM - Seeking Alpha

Generic Launch at Dr. Reddy's - Analyst Blog
10/1/2012 2:49:58 PM - Zacks.com

Why Barron's Article on Opko Health is Myopic
10/1/2012 2:00:11 PM - Trefis

Apple Fell Flat On Its Face Last Week, But...
10/1/2012 12:29:00 PM - Seeking Alpha

Eli Lilly: Buy Before Sola Approval
10/1/2012 11:35:00 AM - Seeking Alpha

Becker Equity Fund Shares Top Stock Picks For Value Investors
9/28/2012 6:53:00 PM - Seeking Alpha

6 Big Name Stocks That Bucked The Recent Market Downtrend
9/28/2012 2:24:00 PM - Seeking Alpha

2 Healthcare Stocks To Watch In The Vaccine Market
9/28/2012 2:20:00 PM - Seeking Alpha

Parexel Gets Sales, Profit Bump From Big Pharma
9/27/2012 2:11:00 PM - Investor's Business Daily

Pfizer, Merck Ink Deals In China To Make Up For Shrinking Revenue
9/27/2012 10:57:00 AM - Seeking Alpha

Amarin - A Likely Buyout Candidate For 2012 - Focusing On The Bigger Picture
9/27/2012 10:33:00 AM - Seeking Alpha

NVS Drugs Get Positive CHMP Opinion - Analyst Blog
9/26/2012 5:16:01 PM - Zacks.com

Merck's Dividend - The Good And The Bad
9/26/2012 3:09:00 PM - Seeking Alpha

Mixed Results from Vertex Studies - Analyst Blog
9/26/2012 2:34:33 PM - Zacks.com

U.S., Global Markets Under Pressure as Greece, Euro-Debt in Focus
9/26/2012 12:51:09 PM - MT Newswires

Phase III Data on Novartis' RLX030 - Analyst Blog
9/25/2012 7:27:01 PM - Zacks.com

Another Approval for Amgen's Prolia - Analyst Blog
9/25/2012 5:25:01 PM - Zacks.com

Valuing Drug Stocks, Part II
9/25/2012 8:52:00 AM - Seeking Alpha

Will Abbott's Magic Pill Send Stock Soaring?
9/24/2012 5:10:00 PM - Seeking Alpha

In The Wake Of An FDA Probe, It's Time Questcor Shareholders Begin To Consider Alternatives
9/24/2012 3:20:00 PM - Seeking Alpha